Colonoscopy findings and polyp pathology in CHEK2 carriers: a single center experience

Familial Cancer · Published 2026-06-02 · DOI 10.1007/s10689-026-00574-z

Authors (4)

Joshua Rosario, Sheng Zhou, Nicholas Bartell, Danielle Marino

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Rosario, J., Zhou, S., Bartell, N., et al. (2026). Colonoscopy findings and polyp pathology in CHEK2 carriers: a single center experience. Familial Cancer. https://doi.org/10.1007/s10689-026-00574-z

Related articles

• Familial risks in prostate cancer between brothers and half-brothers as clues to germline genetic and environmental causes · Familial Cancer · 2026 · Same journal
• Attenuated Li–Fraumeni syndrome with TP53 p.R181H in a Japanese patient with metastatic rectal adenocarcinoma: a case report · Familial Cancer · 2026 · Same journal
• Patient-derived outcome assessment of knowledge, communication, and management in those diagnosed with BAP1-tumor predisposition syndrome · Familial Cancer · 2026 · Same journal
• Breast cancer phenotypes in carriers of pathogenic POT1 variants · Familial Cancer · 2026 · Same journal
• Homozygous TP53 alterations: a case of a biallelic splice variant and a brief review of the literature · Familial Cancer · 2026 · Same journal
• Genotypic and phenotypic characteristics of germline TP53 variant carriers: experience from two cancer genetic counseling units · Familial Cancer · 2026 · Same journal
• When screentime fails: initiative to improve completion of hereditary cancer genetic testing after telemedicine counseling · Familial Cancer · 2026 · Same journal
• Trends in breast reconstruction for BRCA1/2, PALB2 and other high penetrance germline pathogenic variant carriers undergoing risk reducing mastectomy · Familial Cancer · 2026 · Same journal
• Biallelic germline MBD4 mutations predispose to colorectal polyposis, hypermutated AML, and schwannomas · Familial Cancer · 2026 · Same journal
• Determinants of the quality of life of patients with NF2-related schwannomatosis and validation of the Dutch NFTI-QOL questionnaire · Familial Cancer · 2026 · Same journal